Inhibition by lysophosphatidylcholine of nitric oxide production in interleukin 1 beta-stimulated vascular smooth muscle cells
- PMID: 10352496
Inhibition by lysophosphatidylcholine of nitric oxide production in interleukin 1 beta-stimulated vascular smooth muscle cells
Abstract
In vascular smooth muscle cells (VSMC), inflammatory cytokines such as interleukin 1 beta(IL-1 beta) stimulated nitric oxide (NO) production via the expression of an inducible type of NO synthase (iNOS). Lysophosphatidylcholine (LPC) is a major phospholipid component of atherogenic oxidized low density lipoprotein (Ox-LDL). In this study, we examined the effect of LPC on IL-1 beta-stimulated NO production in cultured. VSMC. LPC by itself did not stimulate the production of nitrite, a stable metabolite of NO, but dose-dependently inhibited IL-1 beta-stimulated nitrite production. LPC inhibited IL-1 beta-stimulated iNOS protein expression, whereas LPC did not inhibit IL-1 beta-stimulated iNOS mRNA expression. Analysis of iNOS protein degradation rate revealed that LPC had no effect on degradation rate of iNOS protein, suggesting that LPC inhibited iNOS translation. Moreover, Ox-LDL inhibited IL-1 beta-stimulated NO production by inhibiting iNOS protein expression without affecting iNOS mRNA expression. These results indicate that Ox-LDL negatively modulates IL-1 beta-induced NO production through the action of LPC, probably by blocking translation of iNOS mRNA.
Similar articles
-
Angiotensin II type 1 receptor-mediated inhibition of cytokine-stimulated inducible nitric oxide synthase expression in vascular smooth muscle cells.Blood Press Suppl. 1994;5:32-7. Blood Press Suppl. 1994. PMID: 7534178
-
[Modulation of sphingosine 1-phosphate, a new lipid mediator, on nitric oxide production by vascular smooth muscle cells].Nihon Yakurigaku Zasshi. 2002 Nov;120(1):70P-72P. Nihon Yakurigaku Zasshi. 2002. PMID: 12491784 Japanese.
-
Diabetes undermines estrogen control of inducible nitric oxide synthase function in rat aortic smooth muscle cells through overexpression of estrogen receptor-beta.Circulation. 2003 Jul 15;108(2):211-7. doi: 10.1161/01.CIR.0000079311.39939.94. Epub 2003 Jun 23. Circulation. 2003. PMID: 12821541
-
Role of lysophosphatidylcholine (LPC) in atherosclerosis.Curr Med Chem. 2007;14(30):3209-20. doi: 10.2174/092986707782793899. Curr Med Chem. 2007. PMID: 18220755 Review.
-
Metabolism and atherogenic disease association of lysophosphatidylcholine.Atherosclerosis. 2010 Jan;208(1):10-8. doi: 10.1016/j.atherosclerosis.2009.05.029. Epub 2009 Jun 6. Atherosclerosis. 2010. PMID: 19570538 Review.
Cited by
-
An Updated Review of Pro- and Anti-Inflammatory Properties of Plasma Lysophosphatidylcholines in the Vascular System.Int J Mol Sci. 2020 Jun 24;21(12):4501. doi: 10.3390/ijms21124501. Int J Mol Sci. 2020. PMID: 32599910 Free PMC article. Review.